Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    April 2017
  1. KAHAN T
    Target blood pressure in patients at high cardiovascular risk.
    Lancet. 2017 Apr 5. pii: S0140-6736(17)30935.
    PubMed     Text format    


  2. BOHM M, Schumacher H, Teo KK, Lonn EM, et al
    Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Lancet. 2017 Apr 5. pii: S0140-6736(17)30754.
    PubMed     Text format     Abstract available


  3. VIDAL-PETIOT E, Bhatt DL, Fox KM, Steg PG, et al
    Blood pressure and cardiovascular outcomes: a closer look - Authors' reply.
    Lancet. 2017;389:1296-1297.
    PubMed     Text format    


  4. WALD NJ, Wald DS
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1296.
    PubMed     Text format    


  5. DOUMAS M, Stavropoulos KV, Boutari C, Imprialos KP, et al
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1295-1296.
    PubMed     Text format    


    March 2017
  6. SCHOOLING CM
    Tachykinin neurokinin 3 receptor antagonists: a new treatment for cardiovascular disease?
    Lancet. 2017 Mar 27. pii: S0140-6736(16)31648.
    PubMed     Text format     Abstract available


  7. GURBEL PA, Tantry US
    GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes.
    Lancet. 2017 Mar 17. pii: S0140-6736(17)30760.
    PubMed     Text format    


  8. OHMAN EM, Roe MT, Steg PG, James SK, et al
    Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Lancet. 2017 Mar 17. pii: S0140-6736(17)30751.
    PubMed     Text format     Abstract available


  9. KAPLAN H, Thompson RC, Trumble BC, Wann LS, et al
    Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study.
    Lancet. 2017 Mar 16. pii: S0140-6736(17)30752.
    PubMed     Text format     Abstract available


  10. THE LANCET
    Polypills: an essential medicine for cardiovascular disease.
    Lancet. 2017;389:984.
    PubMed     Text format    


  11. HUFFMAN MD, Xavier D, Perel P
    Uses of polypills for cardiovascular disease and evidence to date.
    Lancet. 2017;389:1055-1065.
    PubMed     Text format     Abstract available


    January 2017
  12. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    Hypertension control and cardiovascular disease - Authors' reply.
    Lancet. 2017;389:154-155.
    PubMed     Text format    


  13. JAMES JE
    Hypertension control and cardiovascular disease.
    Lancet. 2017;389:154.
    PubMed     Text format    


  14. MESSERLI FH, Fischer U, Rimoldi SF, Bangalore S, et al
    Hypertension control and cardiovascular disease.
    Lancet. 2017;389:153.
    PubMed     Text format    


  15. TAWAKOL A, Ishai A, Takx RA, Figueroa AL, et al
    Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.
    Lancet. 2017 Jan 12. pii: S0140-6736(16)31714.
    PubMed     Text format     Abstract available


    November 2016
  16. COLLINS R, Reith C, Emberson J, Armitage J, et al
    Interpretation of the evidence for the efficacy and safety of statin therapy.
    Lancet. 2016;388:2532-2561.
    PubMed     Text format     Abstract available


    October 2016
  17. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Text format     Abstract available


  18. MACK M, Holmes DR
    Randomised trials in left main disease: a NOBLE effort.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32067.
    PubMed     Text format    


  19. VON BIRGELEN C, Kok MM, van der Heijden LC, Danse PW, et al
    Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31920.
    PubMed     Text format     Abstract available


  20. FINN AV, Virmani R
    Biodegradable polymer drug-eluting stents: non-inferiority waiting for superiority?
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32063.
    PubMed     Text format    


  21. ALI ZA, Maehara A, Genereux P, Shlofmitz RA, et al
    Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31922.
    PubMed     Text format     Abstract available


  22. SERRUYS PW, Chevalier B, Sotomi Y, Cequier A, et al
    Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32050.
    PubMed     Text format     Abstract available


  23. ROSSIGNOL P, Pitt B, Thompson A, Zannad F, et al
    Roadmap for cardiovascular prevention trials in chronic kidney disease.
    Lancet. 2016;388:1964-1966.
    PubMed     Text format    


  24. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Text format     Abstract available


  25. ISAAZ K, Gerbay A
    Deferred stenting in acute ST elevation myocardial infarction.
    Lancet. 2016;388:1371.
    PubMed     Text format    


  26. KELBAEK H, Hofsten DE, Engstrom T, Helqvist S, et al
    Deferred stenting in acute ST elevation myocardial infarction - Authors' reply.
    Lancet. 2016;388:1371-1372.
    PubMed     Text format    


  27. WONG EM, Chair SY, Leung DY, Sit JW, et al
    The effect of an e-health web-based support programme on psychological outcomes and health related quality of life among Chinese patients with coronary heart disease: a parallel-group randomised controlled trial.
    Lancet. 2016;388 Suppl 1:S86.
    PubMed     Text format     Abstract available


    September 2016
  28. FEINBERG MW
    No small task: therapeutic targeting of Lp(a) for cardiovascular disease.
    Lancet. 2016 Sep 21. pii: S0140-6736(16)31329.
    PubMed     Text format    


    August 2016
  29. CAYLA G, Cuisset T, Silvain J, Leclercq F, et al
    Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31323.
    PubMed     Text format     Abstract available


  30. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    PubMed     Text format     Abstract available


  31. MANCIA G
    Should blood pressure reduction be aggressive in patients with hypertension and coronary artery disease?
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31398.
    PubMed     Text format    


  32. WEINTRAUB WS
    Invasive management of acute coronary syndromes.
    Lancet. 2016 Aug 25. pii: S0140-6736(16)31273.
    PubMed     Text format    


  33. WALLENTIN L, Lindhagen L, Arnstrom E, Husted S, et al
    Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.
    Lancet. 2016 Aug 25. pii: S0140-6736(16)31276.
    PubMed     Text format     Abstract available


  34. REED GW, Rossi JE, Cannon CP
    Acute myocardial infarction.
    Lancet. 2016 Aug 5. pii: S0140-6736(16)30677.
    PubMed     Text format     Abstract available


    July 2016
  35. SNYDER A
    Philip Majerus.
    Lancet. 2016;388:458.
    PubMed     Text format    


  36. KAIN K
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:126.
    PubMed     Text format    


  37. ETTEHAD D, Emdin CA, Kiran A, Rahimi K, et al
    Blood pressure lowering for cardiovascular disease - Authors' reply.
    Lancet. 2016;388:126-7.
    PubMed     Text format    


  38. O'KEEFFE DT, Maraka S
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125.
    PubMed     Text format    


  39. SMULDERS YM, Muller M
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125-6.
    PubMed     Text format    


  40. COLLINS DR, Albasri A, O'Sullivan J, Bobrovitz N, et al
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125.
    PubMed     Text format    


  41. STONE GW, Gao R, Kimura T, Simonton C, et al
    Optimum technique to reduce risk of stent thrombosis - Authors' reply.
    Lancet. 2016;388:127-8.
    PubMed     Text format    


  42. SHAH R
    Optimum technique to reduce risk of stent thrombosis.
    Lancet. 2016;388:127.
    PubMed     Text format    


    June 2016
  43. GLADWIN MT
    Cardiovascular complications and risk of death in sickle-cell disease.
    Lancet. 2016;387:2565-74.
    PubMed     Text format     Abstract available


  44. TEGN N, Abdelnoor M, Aaberge L, Endresen K, et al
    Invasive strategy in acute coronary syndrome - Authors' reply.
    Lancet. 2016;387:2504.
    PubMed     Text format    


  45. MATHEW ST, Pakala AV, Thadani U
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503-4.
    PubMed     Text format    


  46. SHAH R
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503.
    PubMed     Text format    


  47. TIMMIS A
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503.
    PubMed     Text format    


  48. POVSIC TJ, Zeiher AM
    IxCELL-DCM: rejuvenation for cardiac regenerative therapy?
    Lancet. 2016;387:2362-3.
    PubMed     Text format    


  49. FUJITA T
    Measurement of cardiac troponin for exclusion of myocardial infarction.
    Lancet. 2016;387:2289.
    PubMed     Text format    


  50. FORD C, Whitehead SJ, Gama R, Willmer KA, et al
    Measurement of cardiac troponin for exclusion of myocardial infarction.
    Lancet. 2016;387:2289.
    PubMed     Text format    


  51. SHAH AS, Anand A, Chapman AR, Newby DE, et al
    Measurement of cardiac troponin for exclusion of myocardial infarction - Authors' reply.
    Lancet. 2016;387:2289-91.
    PubMed     Text format    


  52. BOEDDINGHAUS J, Twerenbold R, Nestelberger T, Wildi K, et al
    Measurement of cardiac troponin for exclusion of myocardial infarction.
    Lancet. 2016;387:2288.
    PubMed     Text format    


  53. MULLEN L, Chew PG, Frost F, Obafemi T, et al
    Measurement of cardiac troponin for exclusion of myocardial infarction.
    Lancet. 2016;387:2288-9.
    PubMed     Text format    


  54. DALE A, Slade E, Heneghan C
    Outcomes reporting of the FAME trial.
    Lancet. 2016;387:2292.
    PubMed     Text format    


    May 2016
  55. LAFONT A, Mennuni MG
    Effect on death of scaffold thrombosis versus stent thrombosis.
    Lancet. 2016;387:2198.
    PubMed     Text format    


  56. KAUFMAN JD, Adar SD, Barr RG, Budoff M, et al
    Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study.
    Lancet. 2016 May 24. pii: S0140-6736(16)00378.
    PubMed     Text format     Abstract available


  57. MENTE A, O'Donnell M, Rangarajan S, Dagenais G, et al
    Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.
    Lancet. 2016 May 20. pii: S0140-6736(16)30467.
    PubMed     Text format     Abstract available


  58. SABATE M, Brugaletta S
    Outcomes in the EXAMINATION trial - Authors' reply.
    Lancet. 2016;387:1998.
    PubMed     Text format    


  59. DRYSDALE H, Hartley P, Goldacre B
    Outcomes in the EXAMINATION trial.
    Lancet. 2016;387:1997-8.
    PubMed     Text format    


  60. CASSESE S, Kastrati A
    Risk of stent thrombosis with bioresorbable vascular scaffolds - Authors' reply.
    Lancet. 2016;387:1904.
    PubMed     Text format    


  61. SHAH R, Ramos-Bondy B, Mizeracki A
    Risk of stent thrombosis with bioresorbable vascular scaffolds.
    Lancet. 2016;387:1903.
    PubMed     Text format    


    April 2016
  62. VESTBO J, Anderson JA, Brook RD, Calverley PM, et al
    Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.
    Lancet. 2016;387:1817-1826.
    PubMed     Text format     Abstract available


  63. PATEL AN, Henry TD, Quyyumi AA, Schaer GL, et al
    Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.
    Lancet. 2016 Apr 5. pii: S0140-6736(16)30137.
    PubMed     Text format     Abstract available


  64. KELBAEK H, Hofsten DE, Kober L, Helqvist S, et al
    Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)30072.
    PubMed     Text format     Abstract available


  65. VAN 'T HOF AW, Ottervanger JP
    Primary angioplasty for STEMI: hard to improve upon.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)30123.
    PubMed     Text format    


    February 2016
  66. LIU B, Floud S, Pirie K, Green J, et al
    Does happiness itself directly affect mortality? The prospective UK Million Women Study.
    Lancet. 2016;387:874-81.
    PubMed     Text format     Abstract available



  67. Acute myocardial infarction in women.
    Lancet. 2016;387:506.
    PubMed     Text format    


  68. FINN AV, Virmani R
    The clinical challenge of disappearing stents.
    Lancet. 2016;387:510-2.
    PubMed     Text format    


  69. CASSESE S, Byrne RA, Ndrepepa G, Kufner S, et al
    Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.
    Lancet. 2016;387:537-44.
    PubMed     Text format     Abstract available


  70. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century.
    Lancet. 2016 Feb 5. pii: S0140-6736(16)00002.
    PubMed     Text format    


    January 2016
  71. STONE GW, Gao R, Kimura T, Kereiakes DJ, et al
    1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis.
    Lancet. 2016 Jan 25. pii: S0140-6736(15)01039.
    PubMed     Text format     Abstract available


  72. TEGN N, Abdelnoor M, Aaberge L, Endresen K, et al
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Lancet. 2016 Jan 12. pii: S0140-6736(15)01166.
    PubMed     Text format     Abstract available


  73. PSALTIS PJ, Nicholls SJ
    Management of acute coronary syndrome in the very elderly.
    Lancet. 2016 Jan 12. pii: S0140-6736(16)00036.
    PubMed     Text format    


  74. FROBERT O, James SK
    Coronary thrombus aspiration: a lesson for clinical medicine.
    Lancet. 2016;387:97-8.
    PubMed     Text format    


  75. LAFONT A, Yang Y
    Magnesium stent scaffolds: DREAMS become reality.
    Lancet. 2016;387:3-4.
    PubMed     Text format    


    December 2015
  76. ETTEHAD D, Emdin CA, Kiran A, Anderson SG, et al
    Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Lancet. 2015 Dec 23. pii: S0140-6736(15)01225.
    PubMed     Text format     Abstract available


  77. VALGIMIGLI M, Gargiullo G, Juni P
    Radial versus femoral access for cardiac catheterisation - Authors' reply.
    Lancet. 2015;386:2394.
    PubMed     Text format    


  78. BRIEGER D, Yong A
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2393-4.
    PubMed     Text format    


  79. SHAH R, Gardner JD
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2392-3.
    PubMed     Text format    


  80. DOWLING C, Rao S, Kerr N, Muller D, et al
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2392.
    PubMed     Text format    


    November 2015
  81. XIE X, Atkins E, Lv J, Bennett A, et al
    Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Lancet. 2015 Nov 7. pii: S0140-6736(15)00805.
    PubMed     Text format     Abstract available


  82. LINCOFF AM, Mehran R, Povsic TJ, Zelenkofske SL, et al
    Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.
    Lancet. 2015 Nov 4. pii: S0140-6736(15)00515.
    PubMed     Text format     Abstract available


    October 2015
  83. CAPODANNO D
    Long-term EXAMINATION of drug-eluting stents in acute myocardial infarction.
    Lancet. 2015 Oct 28. pii: S0140-6736(15)00677.
    PubMed     Text format    


  84. SABATE M, Brugaletta S, Cequier A, Iniguez A, et al
    Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.
    Lancet. 2015 Oct 28. pii: S0140-6736(15)00548.
    PubMed     Text format     Abstract available


  85. PALMERINI T, Zoccai GB, Benedetto U, Stone GW, et al
    Mortality risk with dual antiplatelet therapy? - Authors' reply.
    Lancet. 2015;386:1535.
    PubMed     Text format    


  86. SETHI A, Arora R
    Mortality risk with dual antiplatelet therapy?
    Lancet. 2015;386:1534-5.
    PubMed     Text format    


  87. YEH RW, Elmariah S, Doros G, Kereiakes DJ, et al
    Mortality risk with dual antiplatelet therapy?
    Lancet. 2015;386:1533-4.
    PubMed     Text format    


    August 2015
  88. JANLERT U
    Long working hours: an avoidable cause of stroke?
    Lancet. 2015 Aug 19. pii: S0140-6736(15)61000.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: